Involvement of Angiotensin II Type 1 Receptor and Calcium Channel in Vascular Remodeling and Endothelial Dysfunction in Rats with Pressure Overload
- 26 April 2020
- journal article
- research article
- Published by Springer Nature in Current Medical Science
- Vol. 40 (2) , 320-326
Abstract
Summary Vascular remodeling is an adaptive response to various stimuli, including mechanical forces, inflammatory cytokines and hormones. In the present study, we investigated the role of angiotensin II type 1 receptor (AT1R) and calcium channel in carotid artery remodeling in response to increased biomechanical forces by using the transverse aortic constriction (TAC) rat model. TAC was induced on ten-week-old male Sprague-Dawley rats and these models were treated with AT1R blocker olmesartan (1 mg/kg/day) or/and calcium channel blocker (CCB) amlodipine (0.5 mg/kg/day) for 14 days. After the treatment, the right common carotid artery proximal to the band (RCCA-B) was collected for further assay. Results showed that olmesartan, but not amlodipine, significantly prevented TAC-induced adventitial hyperplasia. Similarly, olmesartan, but not amlodipine, signifcantly prevented vascular infammation, as indicated by increased tumor necrosis factor α (TNF-α) and increased p65 phosphorylation, an indicator of nuclear factor κ-light-chain-enhancer of activated B cells (NFκB) activation in RCCA-B. In contrast, both olmesartan and amlodipine reversed the decreased expression of endothelial nitric oxidase synthase (eNOS) and improved endothelium-dependent vasodilation, whereas combination of olmesartan and amlodipine showed no further synergistic protective effects. These results suggest that AT1R was involved in vascular remodeling and inflammation in response to pressure overload, whereas AT1R and subsequent calcium channel were involved in endothelial dysfunction.Keywords
This publication has 31 references indexed in Scilit:
- Treating volume overload in acutely decompensated heart failure: established and novel therapeutic approachesEuropean Heart Journal: Acute Cardiovascular Care, 2012
- Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis studyAmerican Heart Journal, 2012
- Telmisartan and cardioprotectionVascular Health and Risk Management, 2011
- Effect of an acute mechanical stimulus on aortic structure in the transverse aortic constriction mouse modelClinical and Experimental Pharmacology and Physiology, 2011
- Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160)Hypertension Research, 2009
- Comparison of effects of amlodipine and angiotensin receptor blockers on the intima–media thickness of carotid arterial wall (AAA study: Amlodipine vs. ARB in atherosclerosis study)Diabetes Research and Clinical Practice, 2009
- The role of the adventitia in vascular inflammationCardiovascular Research, 2007
- Effect of pressure overload and its recovery on the rat carotid artery: change of vascular reactivity and remodeling processHeart and Vessels, 2006
- Biphasic Survival Response to Amlodipine after Myocardial Infarction in RatsCardiovascular Pathology, 2000
- Relaxation of potassium chloride-induced contractions by amlodipine and its interaction with the 1,4-dihydropyridine-binding site in pig coronary arteryThe American Journal of Cardiology, 1989